reports
TGS Awards Performance Share Units and Restricted Share Units
TGS Awards Performance Share Units and Restricted Share Units Oslo, Norway (15 August 2025) – TGS has issued awards of Performance Share Units (PSUs) and Restricted Share Units (RSUs) to 283 key employees of the Company, as authorized by the shareholders of the company at its Annual General Meeting on 8 May 2025. With the exception of certain PSUs and RSUs, which may be secured by the Company’s treasury stock, the PSUs and RSUs are secured by free-standing warrants that, upon vesting of the PSUs and RSUs in accordance with their terms, are convertible to shares of the Company’s common stoc...
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Capital Increase in Genmab as a Result of Employee Warrant Exercise Company Announcement COPENHAGEN, Denmark; August 12, 2025 – (Nasdaq: GMAB) will increase its share capital by 4,563 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 2,580 shares at DKK 1,025.00,1,874 shares at DKK 1,050.00, and109 shares at DKK 1,161.00. Proceeds to the company are approximately DKK 4.7 million....
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
TGS Vesting Under the 2022 Long-term Incentive Plan
TGS Vesting Under the 2022 Long-term Incentive Plan Oslo, Norway (11 August 2025) – In accordance with the measures approved by the shareholders of TGS at the Annual General Meeting on 11 May 2022, the Board of Directors of TGS ASA authorized TGS to grant Performance Stock Units (PSUs) and Restricted Stock Units (RSUs) under the 2022 Long Term Incentive Plan to key employees of TGS on 9 August 2022. Each RSU represented the right to receive one share, while each PSU represented the right to receive a maximum of one share depending on performance against target metrics during the measuremen...
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Lars Trongaard Brattli
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Energy Research
- Åsne Holsen
- Daniel Vårdal Haugland
- John Olaisen
- Stian Wibstad
TGS Awarded Streamer Acquisition Contract
TGS Awarded Streamer Acquisition Contract OSLO, Norway (8 August 2025) – TGS, a leading provider of energy data and intelligence, is pleased to announce the award of a streamer acquisition contract in the East Mediterranean. Acquisition is scheduled to commence in Q3 this year and the contract has a duration of approximately 30 days. Kristian Johansen, CEO of TGS, commented, "We are very pleased to secure this additional streamer contract. By leveraging the Ramform acquisition platform, coupled with our proprietary GeoStreamer technology we are well equipped to deliver the highest data qu...
Genmab Announces Financial Results for the First Half of 2025
Genmab Announces Financial Results for the First Half of 2025 August 7, 2025 Copenhagen, Denmark; Interim Report for the First Half Ended June 30, 2025 Highlights Epcoritamab advancing to earlier lines of therapy with the submission of a sBLA to the FDA for epcoritamab plus R2 in patients with relapsed or refractory FLRinatabart sesutecan (Rina-S®) continues to progress, demonstrating encouraging antitumor activity in endometrial cancer in data presented at the 2025 ASCO Annual MeetingData from over 40 abstracts highlighting the depth, breadth and strength of Genmab’s comprehensive epcori...
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary ...
Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Company Announcement COPENHAGEN, Denmark; August 7, 2025 Epcoritamab in combination with rituximab and lenalidomide (R2) demonstrated statistically significant improvement in Overall Response Rate (ORR; 95.7%, p < 0.0001) and Progression-Free Survival (HR 0.21, p-value
NCC AB: 1 director
A director at NCC AB bought 250,000 shares at 185.543SEK and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
- ABGSC Shipping & Transport Research
- Henrik Bartnes
- Petter Nystrøm
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Construct. & Real Estate Research
- Fredrik Stensved
- Oscar Lindquist
- Filipe Botelho
- Haidje Rustau
- Jayanth Kandalam
- Peter Low
- Si Yong Ng
- ABGSC Oil & Oil Services Research
- John Olaisen
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
- ABGSC Oil & Oil Services Research
- John Olaisen
TGS Quarterly Dividend
TGS Quarterly Dividend OSLO, NORWAY (17 July 2025) – Following the authorization from the Annual General Meeting on 8 May 2025, the Board of TGS ASA has resolved to distribute a quarterly dividend of the NOK equivalent of USD 0.155 per share (NOK 1.58 per share) in Q3 2025. Key information relating to the cash dividend: Dividend amount and declared currency: USD 0.155 per share (equivalent to NOK 1.58 per share)Last trading day including right: 23 July 2025 Ex-date: 24 July 2025Record date: 25 July 2025Payment date: 7 August 2025 Date of approval: 16 July 2025 About TGS TGS ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.